Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells

BACKGROUND: Chemoresistance is a serious problem in pancreatic cancer, but the mechanism of resistance and strategies against the resistance have not been elucidated. We examined the potential of the phosphatidylinositol 3-kinase (PI3K)/Akt inhibitor LY294002 to enhance the anti-tumor effect of cisp...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Masao, Izuishi, Kunihiko, Sano, Takanori, Hossain, Mohammad Akram, Kimura, Shoji, Masaki, Tsutomu, Suzuki, Yasuyuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607265/
https://www.ncbi.nlm.nih.gov/pubmed/19032736
http://dx.doi.org/10.1186/1756-9966-27-76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607265/
https://www.ncbi.nlm.nih.gov/pubmed/19032736
http://dx.doi.org/10.1186/1756-9966-27-76

Ejemplares similares